Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures
Calcified Tissue International · 2023
DOI: 10.1007/s00223-023-01066-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Calcified Tissue International, 2023. Verfasst von Sanne Treurniet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine Section Endocrinology, Rare Bone Disease Center, Amsterdam, Movement Sciences, Amsterdam UMC, location Vrije Universi…. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Osteoporosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Stillen
Abstract (Originalsprache)
Pregnancy- and lactation-associated osteoporosis (PLO) is a rare form of osteoporosis, of which the pathogenesis and best treatment options are unclear. In this report, we describe the case of a 34-year old woman diagnosed with severe osteoporosis and multiple vertebral fractures after her first pregnancy, who was subsequently treated with teriparatide (TPTD) and zoledronic acid (ZA). We describe the clinical features, imaging examination, and genetic analysis. Substantial improvements were observed in areal and volumetric bone mineral density (BMD), microarchitecture, and strength between 7 and 40 months postpartum as assessed by dual-energy X-ray absorptiometry at the total hip and spine and by high-resolution peripheral quantitative CT at the distal radius and tibiae. At the hip, spine, and distal radius, these improvements were mainly enabled by treatment with TPTD and ZA, while at the distal tibiae, physiological recovery and postpartum physiotherapy due to leg pain after stumbling may have played a major role. Additionally, the findings show that, despite the improvements, BMD, microarchitecture, and strength remained severely impaired in comparison with healthy age- and gender-matched controls at 40 months postpartum. Genetic analysis showed no monogenic cause for osteoporosis, and it is suggested that PLO in this woman could have a polygenic origin with possible susceptibility based on familiar occurrence of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine Section Endocrinology, Rare Bone Disease Center, Amsterdam, Movement Sciences, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands.
- NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
- Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
- Department of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
- Department of Human Genetics, Amsterdam Movement Sciences, Amsterdam Rare Bone Disease/Amsterdam Bone Center, Amsterdam University Medical Center, location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The…
ORCID-Profile: Sanne Treurniet, Melissa S A M Bevers, Caroline E Wyers, Dimitra Micha, Bernd P Teunissen, Mariet W Elting, Joop P van den Bergh, Elisabeth M W Eekhoff
Zitieren
APA
Treurniet, S., Bevers, M. S. A. M., Wyers, C. E., Micha, D., Teunissen, B. P., Elting, M. W., van den Bergh, J. P., & Eekhoff, E. M. W. (2023). Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures. Calcified Tissue International. https://doi.org/10.1007/s00223-023-01066-3
Vancouver
Treurniet S, Bevers MSAM, Wyers CE, Micha D, Teunissen BP, Elting MW, et al. Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures. Calcified Tissue International. 2023. doi:10.1007/s00223-023-01066-3
BibTeX
@article{Treurniet2023,
author = {Treurniet, Sanne and Bevers, Melissa S A M and Wyers, Caroline E and Micha, Dimitra and Teunissen, Bernd P and Elting, Mariet W and van den Bergh, Joop P and Eekhoff, Elisabeth M W},
title = {Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures},
journal = {Calcified Tissue International},
year = {2023},
doi = {10.1007/s00223-023-01066-3}
}
EUVIMED